Jeff Yass’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Jeff Yass's RCUS Position: Q3 2026 in Review
Jeff Yass increased its Arcus Biosciences (RCUS) stake by 4,078% in Q3 2026, buying an estimated $8.61M and bringing the position to 312,875 shares worth $8.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3656.
Jeff Yass first reported a position in RCUS in Q2 2019 and has held it in 28 quarters since. The position peaked at $8.15M in Q4 2025. 243 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Jeff Yass held 312,875 shares of Arcus Biosciences worth $8.08M as of Q3 2026.
- Jeff Yass bought 305,387 Arcus Biosciences shares in Q3 2026, an estimated $8.61M.
- Arcus Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #3656 holding.
- Jeff Yass first reported a position in Arcus Biosciences in Q2 2019 and has held it in 28 quarters since.
- Jeff Yass's Arcus Biosciences position peaked at $8.15M in Q4 2025.
- 243 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.